Sheikh AAE, Sheikh AB, Shah I, Khair AH, Javed N, Shekhar R. COVID-19 and Fulminant
Clostridium difficile Colitis Co-Infection.
Eur J Case Rep Intern Med 2021;
8:002771. [PMID:
34527627 DOI:
10.12890/2021_002771]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Accepted: 07/17/2021] [Indexed: 01/22/2023] Open
Abstract
The development of Clostridium difficile infection in COVID-19 patients is an understudied complication of the disease. Herein, we present the case of a 46-year-old man who developed severe healthcare-associated C. difficile infection leading to toxic megacolon and perforation in the setting of COVID-19 infection. It is important to continue to follow guidelines regarding antibiotics in healthcare settings to prevent such complications.
LEARNING POINTS
Co-infection with Clostridium difficile and COVID-19 leads to poor outcomes with high mortality.C. difficile infection should be ruled out in COVID-19 patients who develop diarrhoea on antibiotic therapy.We should continue to follow the established guidelines of antimicrobial stewardship and remain vigilant for unexpected adverse effects.
Collapse